Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123863 · ClinicalTrials.gov registry record
The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
A clinical trial of Sickle Cell Disease, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 248
- Enrollment target
- 1
- Study location
NCT01123863 is a study of Sickle Cell Disease that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 248 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01123863, a study of Sickle Cell Disease, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
A preliminary study was conducted involving 88 three-year-old children with sickle cell disease (SCD) who were followed at the St. Jude Children's Research Hospital Sickle Cell Center. They were offered developmental screening with the Brigance Preschool Screen-II test during their regular clinic visits from January 2006 to August 2008. Data from this work showed that 50% of 3 year old children with SCD had low developmental screening scores. In addition, the low scores were found to be associated with less parental education and with speech deficits. However they were not associated with sickle cell genotype and hemoglobin level. The primary goal of this study is to prospectively administer Brigance Preschool Screen -II to 3 year old children with SCD and 3 year old children without SCD who come from similar socioeconomic backgrounds and compare the results between the two groups.
Conditions Studied
Interventions
- OTHER Brigance Preschool Screen -II
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2010-05 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123863
The ClinicalTrials.gov registry entry for NCT01123863 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (15% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Brigance Preschool Screen -II is the first listed.
NCT01123863 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01123863 about?
NCT01123863 is a clinical study titled "The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2". A preliminary study was conducted involving 88 three-year-old children with sickle cell disease (SCD) who were followed at the St. Jude Children's Research Hospital Sickle Cell Center. They were offered developmental screening with the Brigance Preschool Screen-II test during their regular clinic vi...
What is the current status of trial NCT01123863?
This trial is currently completed. The enrollment target is 248 participants. The study started on 2010-05. Estimated completion is 2015-05.
What conditions does trial NCT01123863 study?
This clinical trial studies the following conditions: Sickle Cell Disease.
What interventions are being tested in trial NCT01123863?
The interventions under investigation include: Brigance Preschool Screen -II (OTHER).
Who is sponsoring clinical trial NCT01123863?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01123863 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
RECRUITING · Phase 2
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
RECRUITING · Phase 1
-
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.